The revenue of Change Healthcare Inc. with headquarters in the United States amounted to 3.5 billion U.S. dollars in 2021. The reported fiscal year ends on March 31.Compared to the earliest depicted value from 2019 this is a total increase by approximately 3.3 billion U.S. dollars. The trend from 2019 to 2021 shows, furthermore, that this increase happened continuously.

The revenue change in the digital health market in Indonesia was forecast to continuously decrease between 2024 and 2029 by in total 5.3 percentage points. After the fourth consecutive decreasing year, the revenue change is estimated to reach 4.62 percent and therefore a new minimum in 2029. The Statista Market Insights cover a broad range of additional markets.

The ongoing trends in the value-based healthcare service market have favored it to garner a revenue of around US$ 3,281.2 million in 2024. The worldwide adoption of value-based healthcare services is spurring and could meet a growth rate of 6.5% during the forecast period. Analysis of the value-based healthcare industry trends suggests the market has the capacity to generate a revenue of US$ 6,184.2 million by 2034.

Value-based Healthcare Service Market Historical Analysis (2019 to 2023) Vs Forecast Outlook (2024 to 2034)

Country-wise Insights

Category-wise Insights

Value-based Healthcare Service Market Report Scope

The revenue in the 'Digital Fitness & Well-Being' segment of the digital health market in China was forecast to continuously increase between 2024 and 2029 by in total 4.1 billion U.S. dollars (+39.81 percent). After the tenth consecutive increasing year, the indicator is estimated to reach 14.38 billion U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the 'Digital Fitness & Well-Being' segment of the digital health market was continuously increasing over the past years.Find further information concerning the average revenue per user in the 'Fitness Trackers' segment of the digital health market in Cameroon and the revenue change in the 'Fitness Trackers' segment of the digital health market in Belgium. The Statista Market Insights cover a broad range of additional markets.

The revenue change in the 'In Vitro Diagnostics' segment of the medical technology market in Canada was forecast to increase between 2024 and 2029 by in total 2.8 percentage points. This overall increase does not happen continuously, notably not in 2029. The revenue change is estimated to amount to 3.56 percent in 2029. Find further information regarding revenue in the United States and revenue growth in the United States. The Statista Market Insights cover a broad range of additional markets.

The revenue change in the 'In Vitro Diagnostics' segment of the medical technology market in the United States was forecast to continuously increase between 2024 and 2029 by in total 4.2 percentage points. According to this forecast, in 2029, the revenue change will have increased for the sixth consecutive year to 3.36 percent. Find further information regarding revenue in Canada and revenue growth in Canada. The Statista Market Insights cover a broad range of additional markets.

This dataset contains Hospital Chargemasters with prices in effect as of June 1 of their reporting year. Chargemasters consists of a list of average charges for 25 common outpatient procedures, and the estimated percentage change in gross revenue due to price changes each July 1.

For more on HCAI Chargemaster Data.

Download Free Sample
The bone cement market is expected to grow at a CAGR of 5% during the forecast period. Increasing rate of adoption of minimally invasive techniques, drivers.2, and drivers.3 are some of the significant factors fueling bone cement market growth.

Increasing rate of adoption of minimally invasive techniques

Technavio categorizes the global bone cement market as a part of the global healthcare supplies market that primarily covers manufacturers of medical products, including all categories of supplies such as consumables and disposables like safety needles, syringes, and catheters. The parent, global healthcare supplies market, covers products and companies engaged in R&D of a variety of product categories spanned across medical consumables that are used for the diagnosis and treatment of various diseases. The global healthcare market was valued at $1.72 trillion in 2019 and is expected to grow at a moderate pace. The global healthcare supplies market, which is a part of the global healthcare market, was valued at $27.31 bn in the same year. Technavio calculates the global healthcare supplies market size based on the combined revenue generated by manufacturers of medical supplies such as syringes, drapes, gloves, and gowns. Growth in the global healthcare supplies market will be driven by the following factors: Increasing life expectancy: The proportion of the global population over the age of 60 years is forecast to increase significantly. By 2050, nearly one-fourth of the US population is projected to be over 60 years, while Europe is likely to reach a similar proportion by 2030. Moreover, some large economies in Asia, such as Japan, already has one-third of its population above 60 years of age. China is expected to have almost half of its population above 60 years by around 2050. This geriatric population requires more medical attention leading to higher spending on healthcare. Expanding access to improved healthcare in emerging economies: With good economic growth across emerging markets in Asia and Africa, since 2000, leading to higher income levels, access to healthcare has also improved. The governments are also spending more on healthcare with a focus on improving the quality of care. Most of this growth has come from emerging countries and low-income regions. Sedentary lifestyle gaining pace: Sedentary lifestyle is the consequence of urbanization, an unhealthy diet, and decreasing levels of physical activity. It is a significant global health concern, with about one-fourth of the population in large economies like the US and China leading a physically inactive lifestyle. A sedentary lifestyle is anticipated to influence and change the nature of healthcare spending. Technavio expects healthcare spending to increase and move away from communicable diseases to chronic care. Increase in cases of chronic conditions: The number of chronic disease cases has been rising globally. The majority of the US population currently lives with at least one chronic condition. In 2018, China reached a “tipping point” by recording the highest number of early deaths due to chronic diseases. Going forward, the incidence of chronic cases is expected to be much higher than that of infectious diseases. Increasing number of surgical procedures: The increase in the number of surgical procedures due to the growing prevalence of various disorders requiring surgical interventions, and the rise in chronic conditions, apart from increasing cases of accidents and injuries, is leading to a rise in demand for medical supplies. Growing focus on infection control: Globally, hospital-acquired infections are major sources of concern among people receiving healthcare. For middle- and low-income economies, the rate of infection is much higher compared with patients in developed economies who receive healthcare of better quality. One way of countering this is to improve the conditions of healthcare facilities and provide healthcare supplies of better quality. Demand for better healthcare will push sales: Rapid urbanization in developing economies in Asia has created a demand for a high standard of healthcare and is expected to drive volume sales of healthcare supplies. Growth generated by emerging segments in healthcare: Growing adoption of healthcare supplies for home-based healthcare, home medical devices, and other advanced application areas such as robotic surgery will aid in the growth of this market. Increased healthcare spend is driving healthcare budgets. It is pushing governments to create cost pressure in the sector, which is a challenge. Some of the key cost and other pressures faced by the healthcare sector are listed below. Pricing pressure by governments: To reduce per capita healthcare spending, governments are increasingly trying to reduce costs related to the various stakeholders that include insurers, healthcare institutions, and manufacturers. Reimbursement reforms: To make healthcare more affordable for

This statistic depicts the percentage of medical companies worldwide that experienced an increase in worldwide sales/turnover in 2019. According to the survey, 32 percent of respondents reported a 1-5% increase in their company's sales.

In the year 2023, the CVS Health Corporation generated approximately 357.8 billion U.S. dollars of revenue in total, an increase compared to the previous years. This value is the highest ever registered in the considered time frame. The fiscal year end of the company is December 31st, 2023. CVS’ history and facts The CVS Health Corporation is a healthcare company, with three major segments: CVS Pharmacy, Caremark Pharmacy Services, and MinuteClinic. It was founded in Lowell, Massachusetts, in 1963 by Stanley and Sidney Goldstein and is currently headquartered in Woonsocket, Rhode Island. The name CVS stands for “Consumer Value Stores”, but in the past, the company name went through a few changes. In fact, it was first called CVS Corporation, which was then changed to CVS Caremark Corporation and finally to CVS Health Corporation. Throughout the decades, CVS kept expanding in the United States and as of 2020, it was one of the leading drug stores accounting for the most outlets in the North American country. Since the year 2005, the number of CVS stores increased notably and at the end of 2020, the company owned about 9,962 stores. As of 2021, the company also started administering COVID-19 tests and vaccines in about 10,000 CVS Pharmacy locations. CVS’ success As of the year 2022, CVS Health’s total assets amounted to approximately 228 billion U.S. dollars: this value has seen an increasing trend since 2005, which is proof of the company's consistently rising success. Moreover, according to forecasts, the company’s revenue is expected to reach around 270.63 billion U.S. dollars in 2025. In the first quarter of 2022, CVS Health also turned out to be very appreciated by its customers: survey results show that, in that period, it was the leading drug store with the highest consumer loyalty score in the United States.